4//SEC Filing
Harris Theodore L 4
Accession 0001140361-24-009271
CIK 0000009326other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:37 PM ET
Size
22.8 KB
Accession
0001140361-24-009271
Insider Transaction Report
Form 4
BALCHEM CORPBCPC
Harris Theodore L
DirectorChairman, President & CEO
Transactions
- Sale
Common Stock
2024-02-22$155.25/sh−5,864$910,380→ 66,412 total - Exercise/Conversion
Stock Options (right to buy)
2024-02-22+24,350→ 0 totalExercise: $60.85Exp: 2026-02-23→ Common Stock (24,350 underlying) - Sale
Common Stock
2024-02-21$152.97/sh−10,797$1,651,658→ 85,294 total - Sale
Common Stock
2024-02-21$154.84/sh−2,667$412,947→ 66,612 total - Exercise/Conversion
Common Stock
2024-02-22$54.87/sh+10,000$548,700→ 76,412 total - Sale
Common Stock
2024-02-22$153.56/sh−14,497$2,226,107→ 86,265 total - Sale
Common Stock
2024-02-22$154.66/sh−13,989$2,163,539→ 72,276 total - Exercise/Conversion
Stock Options (right to buy)
2024-02-22+10,000→ 0 totalExercise: $54.87Exp: 2025-04-28→ Common Stock (10,000 underlying) - Sale
Common Stock
2024-02-21$153.75/sh−16,015$2,462,244→ 69,279 total - Sale
Common Stock
2024-02-21$155.91/sh−200$31,182→ 66,412 total - Exercise/Conversion
Common Stock
2024-02-22$60.85/sh+24,350$1,481,698→ 100,762 total
Footnotes (9)
- [F1]This transaction was executed in multiples sales ranging from $152.3350 to $153.3200 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- [F2]This transaction was executed in multiples sales ranging from $153.3400 to $154.2900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- [F3]This transaction was executed in multiples sales ranging from $154.4700 to $155.3800 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- [F4]Exercise of fully vested non-qualified stock options.
- [F5]This transaction was executed in multiple sales ranging from $153.0800 to $154.0775 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- [F6]This transaction was executed in multiple sales ranging from $154.0800 to $155.0750 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- [F7]This transaction was executed in multiple sales ranging from $155.0800 to $155.5700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- [F8]Stock options that vested 20% on April 28, 2016, 40% on April 28, 2017, and 40% on April 28, 2018, and are exercisable.
- [F9]Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable.
Documents
Issuer
BALCHEM CORP
CIK 0000009326
Entity typeother
Related Parties
1- filerCIK 0001378228
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:37 PM ET
- Size
- 22.8 KB